• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子诱导蛋白 8 样蛋白 2 通过靶向巨噬细胞中的 TLR4 减轻心肌肥厚。

Tumor Necrosis Factor--Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages.

机构信息

Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Oxid Med Cell Longev. 2022 Apr 26;2022:9469143. doi: 10.1155/2022/9469143. eCollection 2022.

DOI:10.1155/2022/9469143
PMID:35528518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072033/
Abstract

BACKGROUND

Tumor necrosis factor--induced protein 8-like 2 (TIPE2), a novel immunoregulatory protein, has been reported to regulate inflammation and apoptosis. The role of TIPE2 in cardiovascular disease, especially cardiac hypertrophy, has not been elucidated. Thus, the aim of the present study was to explore the role of TIPE2 in cardiac hypertrophy.

METHODS

Mice were subjected to aortic banding (AB) to induce an adverse hypertrophic model. To overexpress TIPE2, mice were injected with a lentiviral vector expressing TIPE2. Echocardiographic and hemodynamic analyses were used to evaluate cardiac function. Neonatal rat cardiomyocytes (NRCMs) and mouse peritoneal macrophages (MPMs) were isolated and stimulated with angiotensin II. NRCMs and MPM were also cocultured and stimulated with angiotensin II. Cells were transfected with Lenti-TIPE2 to overexpress TIPE2.

RESULTS

TIPE2 expression levels were downregulated in hypertrophic mouse hearts and in macrophages in heart tissue. TIPE2 overexpression attenuated pressure overload-induced cardiac hypertrophy, fibrosis, and cardiac dysfunction. Moreover, we found that TIPE2 overexpression in neonatal cardiomyocytes did not relieve the angiotensin II-induced hypertrophic response in vitro. Furthermore, TIPE2 overexpression downregulated TLR4 and NF-B signaling in macrophages but not in cardiomyocytes, which led to diminished inflammation in macrophages and consequently reduced the activation of hypertrophic Akt signaling in cardiomyocytes. TLR4 inhibition by TAK-242 did not enhance the antihypertrophic effect of TIPE2 overexpression.

CONCLUSIONS

The present study indicated that TIPE2 represses macrophage activation by targeting TLR4, subsequently inhibiting cardiac hypertrophy.

摘要

背景

肿瘤坏死因子诱导蛋白 8 样蛋白 2(TIPE2)是一种新型的免疫调节蛋白,已被报道可调节炎症和细胞凋亡。TIPE2 在心血管疾病中的作用,特别是心肌肥厚,尚未阐明。因此,本研究旨在探讨 TIPE2 在心肌肥厚中的作用。

方法

通过主动脉缩窄(AB)使小鼠产生不利的肥厚模型来使小鼠产生 TIPE2 过表达,向小鼠注射表达 TIPE2 的慢病毒载体。使用超声心动图和血流动力学分析来评估心脏功能。分离和刺激新生大鼠心肌细胞(NRCMs)和小鼠腹腔巨噬细胞(MPMs),用血管紧张素 II 刺激 NRCMs 和 MPMs 进行共培养。用 Lenti-TIPE2 转染细胞以过表达 TIPE2。

结果

TIPE2 的表达水平在肥厚的小鼠心脏和心脏组织中的巨噬细胞中下调。TIPE2 过表达可减轻压力超负荷引起的心肌肥厚、纤维化和心功能障碍。此外,我们发现 TIPE2 在新生心肌细胞中的过表达不能缓解体外血管紧张素 II 引起的心肌肥厚反应。此外,TIPE2 过表达下调了巨噬细胞中的 TLR4 和 NF-B 信号,但在心肌细胞中没有下调,这导致巨噬细胞中的炎症减少,从而减少心肌细胞中 Akt 信号的激活。TLR4 抑制 TAK-242 并没有增强 TIPE2 过表达的抗肥厚作用。

结论

本研究表明 TIPE2 通过靶向 TLR4 抑制巨噬细胞的激活,从而抑制心肌肥厚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/e38e81f40c18/OMCL2022-9469143.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/ef26aead950a/OMCL2022-9469143.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/e0b3497a3531/OMCL2022-9469143.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/cf90e7357f51/OMCL2022-9469143.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/be6064e9eb32/OMCL2022-9469143.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/b7877c135670/OMCL2022-9469143.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/5591903bae2f/OMCL2022-9469143.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/5f8f1168c9ec/OMCL2022-9469143.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/e38e81f40c18/OMCL2022-9469143.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/ef26aead950a/OMCL2022-9469143.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/e0b3497a3531/OMCL2022-9469143.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/cf90e7357f51/OMCL2022-9469143.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/be6064e9eb32/OMCL2022-9469143.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/b7877c135670/OMCL2022-9469143.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/5591903bae2f/OMCL2022-9469143.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/5f8f1168c9ec/OMCL2022-9469143.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/067e/9072033/e38e81f40c18/OMCL2022-9469143.008.jpg

相似文献

1
Tumor Necrosis Factor--Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages.肿瘤坏死因子诱导蛋白 8 样蛋白 2 通过靶向巨噬细胞中的 TLR4 减轻心肌肥厚。
Oxid Med Cell Longev. 2022 Apr 26;2022:9469143. doi: 10.1155/2022/9469143. eCollection 2022.
2
TRIM-containing 44 aggravates cardiac hypertrophy via TLR4/NOX4-induced ferroptosis.含 TRIM44 的蛋白加剧心脏肥大,通过 TLR4/NOX4 诱导的铁死亡。
J Mol Med (Berl). 2023 Jun;101(6):685-697. doi: 10.1007/s00109-023-02318-3. Epub 2023 Apr 29.
3
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.羽扇豆醇通过 TLR4-PI3K-Akt-NF-κB 通路保护心肌肥厚。
Acta Pharmacol Sin. 2022 Aug;43(8):1989-2002. doi: 10.1038/s41401-021-00820-3. Epub 2021 Dec 16.
4
Reduced expression of transmembrane protein 43 during cardiac hypertrophy leads to worsening heart failure in mice.心肌肥厚时跨膜蛋白 43 的表达减少导致小鼠心力衰竭恶化。
Exp Biol Med (Maywood). 2023 Sep;248(17):1437-1445. doi: 10.1177/15353702231191111. Epub 2023 Sep 11.
5
Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.靶向跨膜 BAX 抑制剂结构域 1 可减轻病理性心肌肥厚。
Circulation. 2018 Apr 3;137(14):1486-1504. doi: 10.1161/CIRCULATIONAHA.117.031659. Epub 2017 Dec 11.
6
Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.Toll 相互作用蛋白(Tollip)负向调节小鼠压力超负荷诱导的心室肥厚。
Cardiovasc Res. 2014 Jan 1;101(1):87-96. doi: 10.1093/cvr/cvt232. Epub 2013 Nov 26.
7
Salidroside ameliorates pathological cardiac hypertrophy via TLR4-TAK1-dependent signaling.红景天苷通过 TLR4-TAK1 依赖性信号通路改善病理性心肌肥厚。
Phytother Res. 2023 May;37(5):1839-1849. doi: 10.1002/ptr.7701. Epub 2022 Dec 13.
8
Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.干扰素调节因子 7 作为一种新型的病理性心肌肥厚负调节剂发挥作用。
Hypertension. 2014 Apr;63(4):713-22. doi: 10.1161/HYPERTENSIONAHA.113.02653. Epub 2014 Jan 6.
9
ANGPTL8 is a negative regulator in pathological cardiac hypertrophy.ANGPTL8 是病理性心肌肥厚的负调节剂。
Cell Death Dis. 2022 Jul 18;13(7):621. doi: 10.1038/s41419-022-05029-8.
10
Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.白细胞免疫球蛋白样受体 B4 通过 SHP-2 依赖性抑制 NF-κB 通路来保护心脏免受肥大。
J Mol Med (Berl). 2020 May;98(5):691-705. doi: 10.1007/s00109-020-01896-w. Epub 2020 Apr 12.

引用本文的文献

1
SARM1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Enhancing NAD Metabolism.SARM1通过增强NAD代谢加剧压力超负荷诱导的心脏肥大和心力衰竭。
FASEB J. 2025 Jul 31;39(14):e70808. doi: 10.1096/fj.202500486RR.
2
TIPE2: a novel regulatory factor for cardiovascular-related diseases.TIPE2:一种心血管相关疾病的新型调控因子。
J Mol Med (Berl). 2025 Jun 19. doi: 10.1007/s00109-025-02564-7.
3
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3.3型心肾综合征的分子机制与治疗策略

本文引用的文献

1
New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction.心肌梗死中巨噬细胞的新见解和新治疗潜力。
Inflammation. 2021 Oct;44(5):1696-1712. doi: 10.1007/s10753-021-01467-2. Epub 2021 Apr 18.
2
A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC).一种新型预后因子 TIPE2 可抑制胰腺导管腺癌(PDAC)细胞增殖并促进细胞凋亡。
Int J Med Sci. 2021 Mar 11;18(9):2051-2062. doi: 10.7150/ijms.51497. eCollection 2021.
3
Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages.
Rev Cardiovasc Med. 2023 Feb 6;24(2):52. doi: 10.31083/j.rcm2402052. eCollection 2023 Feb.
4
Association between skeletal muscle and left ventricular mass in patients with hyperthyroidism.甲状腺功能亢进症患者骨骼肌与左心室质量的关系。
Front Endocrinol (Lausanne). 2024 Jan 31;15:1301529. doi: 10.3389/fendo.2024.1301529. eCollection 2024.
肿瘤坏死因子-α诱导蛋白 8 样蛋白 2 通过靶向巨噬细胞中的 RIG-I 负调控对 RNA 病毒的固有免疫。
Front Immunol. 2021 Mar 19;12:642715. doi: 10.3389/fimmu.2021.642715. eCollection 2021.
4
7-Difluoromethoxy-5,4'-dimethoxy-genistein attenuates macrophages apoptosis to promote plaque stability via TIPE2/TLR4 axis in high fat diet-fed ApoE mice.7-二氟甲氧基-5,4'-二甲氧基染料木黄酮通过 TIPE2/TLR4 轴减轻高脂饮食喂养的 ApoE 小鼠巨噬细胞凋亡,促进斑块稳定。
Int Immunopharmacol. 2021 Jul;96:107477. doi: 10.1016/j.intimp.2021.107477. Epub 2021 Apr 1.
5
Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4.心脏肥大的关键因素,着重探讨Toll样受体4的作用
Front Cardiovasc Med. 2020 Nov 26;7:579036. doi: 10.3389/fcvm.2020.579036. eCollection 2020.
6
YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.YAP/TAZ 缺陷可重塑巨噬细胞表型,并改善心肌梗死后的梗死愈合及心脏功能。
PLoS Biol. 2020 Dec 2;18(12):e3000941. doi: 10.1371/journal.pbio.3000941. eCollection 2020 Dec.
7
Critical roles of macrophages in pressure overload-induced cardiac remodeling.巨噬细胞在压力超负荷诱导的心脏重构中的关键作用。
J Mol Med (Berl). 2021 Jan;99(1):33-46. doi: 10.1007/s00109-020-02002-w. Epub 2020 Oct 31.
8
Role of TLR4 in physical exercise and cardiovascular diseases.TLR4 在运动与心血管疾病中的作用。
Cytokine. 2020 Dec;136:155273. doi: 10.1016/j.cyto.2020.155273. Epub 2020 Sep 12.
9
The Role of Proteostasis in the Regulation of Cardiac Intercellular Communication.蛋白稳态在心脏细胞间通讯调节中的作用。
Adv Exp Med Biol. 2020;1233:279-302. doi: 10.1007/978-3-030-38266-7_12.
10
Gene delivery of TIPE2 attenuates collagen-induced arthritis by modulating inflammation.TIPE2 的基因递送通过调节炎症减轻胶原诱导性关节炎。
Int Immunopharmacol. 2020 Feb;79:106044. doi: 10.1016/j.intimp.2019.106044. Epub 2019 Dec 18.